A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors

Conditions: Refractory Cancer; Recurrent Cancer; Solid Tumor, Adult Interventions: Drug: RO7617991; Drug: Tocilizumab Sponsors: Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials